APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies

NCT03386526 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors or Hematologic Malignancies

Interventions

DRUG: APG-1387 for Injection

Sponsor

Ascentage Pharma Group Inc.